We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 301

Allegations that defendants provided product for “free” state claims under California’s UPA and UCL, notwithstanding that “cost” of product was recouped by overcharging for shipping

  • Sheppard Mullin Richter & Hampton LLP
  • -
  • USA
  • -
  • October 10 2014

Plaintiff Bebe Au Lait sells nursing covers. It was the first company to make and sell, pursuant to patent, a flexible, convex stiffener located

Will Namenda IR withdrawal force a legal switch on product hopping?

  • Fenwick & West LLP
  • -
  • USA
  • -
  • October 3 2014

On September 15, 2014, New York Attorney General Eric Schneiderman filed an anti-trust lawsuit against the specialty pharmaceutical company Forest

Sham-wow! antitrust liability may attach to sham administrative petitions

  • McDermott Will & Emery
  • -
  • USA
  • -
  • October 1 2014

Addressing whether the “sham” exception to Noerr-Pennington immunity is limited to sham litigation in courts, the U.S. Court of Appeals for the

Second Circuit reverses a prior ruling to hold that the Foreign Trade Antitrust Improvements Act restrictions on antitrust claims based on foreign conduct are “nonjurisdictional”

  • Baker & McKenzie
  • -
  • USA
  • -
  • September 24 2014

This dispute concerned the development of the latest industry standard for USB connectors, known as USB 3.0. Plaintiff, a Taiwanese company

Fair play?

  • Pillsbury Winthrop Shaw Pittman LLP
  • -
  • USA
  • -
  • September 20 2014

With blockbuster drugs reaching the end of their patent lives, many companies are looking for new ways to best secure their formulations and protect

Recent FTC “pay-for-delay” development

  • Arnall Golden Gregory LLP
  • -
  • USA
  • -
  • September 9 2014

On Monday, September 8, 2014, the Federal Trade Commission ("FTC") filed a "pay-for-delay" antitrust lawsuit against, inter alia, AbbVie contending

Routine patent litigation giving rise to antitrust liability

  • Gordon & Rees LLP
  • -
  • USA
  • -
  • September 9 2014

On Aug. 6, in Tyco Healthcare Group LP v. Mut. Pharm. Co., Case No. 2013-1386, the Federal Circuit looked at whether antitrust liability can arise

State AGs in the news

  • Dickstein Shapiro LLP
  • -
  • USA
  • -
  • September 4 2014

The AGs of Illinois, Iowa, and Missouri and the U.S. Department of Justice simultaneously filed acomplaint and proposed final judgment in the U.S

Federal Circuit revives certain sham petitioning antitrust counterclaims in Tyco-mutual ANDA litigation

  • Hogan Lovells
  • -
  • USA
  • -
  • August 26 2014

In a split decision, the U.S. Court of Appeals for the Federal Circuit affirmed summary judgment on two antitrust counterclaims brought by Mutual

Split Federal Circuit decision revives antitrust counterclaims in patent litigation

  • Jones Day
  • -
  • USA
  • -
  • August 15 2014

The U.S. Court of Appeals for the Federal Circuit has remanded for further consideration antitrust claims accusing a patent holder of filing a sham